Literature DB >> 15328017

lin-35/Rb and xnp-1/ATR-X function redundantly to control somatic gonad development in C. elegans.

Aaron M Bender1, Orion Wells, David S Fay.   

Abstract

In screens for genetic modifiers of lin-35/Rb, the C. elegans retinoblastoma protein (Rb) homolog, we have identified a mutation in xnp-1. Mutations in xnp-1, including a presumed null allele, are viable and, in general, appear indistinguishable from the wild type. In contrast, xnp-1 lin-35 double mutants are typically sterile and exhibit severe defects in gonadal development. Analyses of the abnormal gonads indicate a defect in the lineages that generate cells of the sheath and spermatheca. xnp-1 encodes the C. elegans homolog of ATR-X, a human disease gene associated with severe forms of mental retardation and urogenital developmental defects. xnp-1/ATR-X is a member of the Swi2/Snf2 family of ATP-dependent DEAD/DEAH box helicases, which function in nucleosome remodeling and transcriptional regulation. Expression of an xnp-1 Colon, two colons GFP promoter fusion is detected throughout C. elegans development in several cell types including neurons and cells of the somatic gonad. Our findings demonstrate a new biological role for Rb family members in somatic gonad development and implicate lin-35 in the execution of multiple cell fates in C. elegans. In addition, our results suggest a possible conserved function for xnp-1/ATR-X in gonadal development across species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328017     DOI: 10.1016/j.ydbio.2004.06.009

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  21 in total

Review 1.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

Review 2.  The SynMuv genes of Caenorhabditis elegans in vulval development and beyond.

Authors:  David S Fay; John Yochem
Journal:  Dev Biol       Date:  2007-03-20       Impact factor: 3.582

3.  gon-14 functions with class B and class C synthetic multivulva genes to control larval growth in Caenorhabditis elegans.

Authors:  Michael A Chesney; Ambrose R Kidd; Judith Kimble
Journal:  Genetics       Date:  2005-12-01       Impact factor: 4.562

4.  A "latent niche" mechanism for tumor initiation.

Authors:  Marie McGovern; Roumen Voutev; John Maciejowski; Ann K Corsi; E Jane Albert Hubbard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

5.  mir-35 is involved in intestine cell G1/S transition and germ cell proliferation in C. elegans.

Authors:  Min Liu; Pengpeng Liu; Li Zhang; Qingchun Cai; Ge Gao; Wenxia Zhang; Zuoyan Zhu; Dong Liu; Qichang Fan
Journal:  Cell Res       Date:  2011-06-21       Impact factor: 25.617

6.  synMuv B proteins antagonize germline fate in the intestine and ensure C. elegans survival.

Authors:  Lisa N Petrella; Wenchao Wang; Caroline A Spike; Andreas Rechtsteiner; Valerie Reinke; Susan Strome
Journal:  Development       Date:  2011-03       Impact factor: 6.868

7.  lin-35/Rb and the CoREST ortholog spr-1 coordinately regulate vulval morphogenesis and gonad development in C. elegans.

Authors:  Aaron M Bender; Natalia V Kirienko; Sara K Olson; Jeffery D Esko; David S Fay
Journal:  Dev Biol       Date:  2006-10-05       Impact factor: 3.582

Review 8.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

9.  A suppressor screen in chlamydomonas identifies novel components of the retinoblastoma tumor suppressor pathway.

Authors:  Su-Chiung Fang; James G Umen
Journal:  Genetics       Date:  2008-03       Impact factor: 4.562

10.  Searching for signaling balance through the identification of genetic interactors of the Rab guanine-nucleotide dissociation inhibitor gdi-1.

Authors:  Anna Y Lee; Richard Perreault; Sharon Harel; Elodie L Boulier; Matthew Suderman; Michael Hallett; Sarah Jenna
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.